| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.53 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |